ABSORPTION, TISSUE DISTRIBUTION, AND EXCRETION OF TRITIUM-LABELED IVERMECTIN IN CATTLE, SHEEP, AND RAT

被引:107
作者
CHIU, SHL
GREEN, ML
BAYLIS, FP
ELINE, D
ROSEGAY, A
MERIWETHER, H
JACOB, TA
机构
[1] Department of Animal and Exploratory Drug Metabolism, Merck Sharp and Dohme Research Laboratories, New Jersey 07065, P.O. Box 2000, Rahway
关键词
D O I
10.1021/jf00101a015
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Tritium-labeled ivermectin was studied in cattle, sheep, and rat for absorption, tissue residue distribution, and excretion at doses of 0.3 mg/kg of body weight. The drug was absorbed by various dosing routes. By intraruminal and subcutaneous dosing routes, highest tissue residues were present in fat and liver of cattle, with half-lives of 6-8 and 4-5 days, respectively. Shorter half-lives (1-2 days) were observed in sheep and rat. The tissue residue distribution pattern was essentially the same for all species studied and similar in male and female rats. With doses of tritium-labeled avermectin B1aranging from 0.06 to 7.5 mg/kg of body weight, plasma and tissue residue concentrations increased proportionally with the dose. When ivermectin was administered by various routes (ip, sc, iv, oral, and intraruminal), blood residue levels converged to 20-50 ppb 4 h after dosing and then depleted at a similar rate regardless of the dosing route. Ivermectin was excreted primarily in the feces, with only less than 2% of the doses being eliminated in the urine in all three species studied. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2072 / 2078
页数:7
相关论文
共 20 条
  • [1] AVERMECTINS, NEW FAMILY OF POTENT ANTHELMINTIC AGENTS - PRODUCING ORGANISM AND FERMENTATION
    BURG, RW
    MILLER, BM
    BAKER, EE
    BIRNBAUM, J
    CURRIE, SA
    HARTMAN, R
    KONG, YL
    MONAGHAN, RL
    OLSON, G
    PUTTER, I
    TUNAC, JB
    WALLICK, H
    STAPLEY, EO
    OIWA, R
    OMURA, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (03) : 361 - 367
  • [2] IVERMECTIN - A POTENT NEW ANTI-PARASITIC AGENT
    CAMPBELL, WC
    FISHER, MH
    STAPLEY, EO
    ALBERSSCHONBERG, G
    JACOB, TA
    [J]. SCIENCE, 1983, 221 (4613) : 823 - 828
  • [3] IVERMECTIN, A NEW BROAD-SPECTRUM ANTI-PARASITIC AGENT
    CHABALA, JC
    MROZIK, H
    TOLMAN, RL
    ESKOLA, P
    LUSI, A
    PETERSON, LH
    WOODS, MF
    FISHER, MH
    CAMPBELL, WC
    EGERTON, JR
    OSTLIND, DA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (10) : 1134 - 1136
  • [4] TRITIUM LABELING OF AVERMECTINS-B1A AND AVERMECTIN-B2A VIA STEREOSELECTIVE REDUCTION OF 5-KETOAVERMECTINS
    CHABALA, JC
    ROSEGAY, A
    WALSH, MAR
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1981, 29 (04) : 881 - 884
  • [5] CHIU SHL, 1984, DRUG METAB DISPOS, V12, P464
  • [6] CHIU SHL, 1988, DRUG METAB DISPOS, V16, P728
  • [7] CHIU SHL, 1986, DRUG METAB DISPOS, V14, P590
  • [8] DEPLETION OF [C-14] CLORSULON IN COWS MILK
    CHIU, SHL
    BAYLIS, FP
    TAUB, R
    GREEN, M
    HALLEY, BA
    BODDEN, RM
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1989, 37 (03) : 819 - 823
  • [9] COMPARATIVE INVIVO AND INVITRO METABOLISM OF IVERMECTIN IN STEERS, SHEEP, SWINE, AND RAT
    CHIU, SHL
    TAUB, R
    SESTOKAS, E
    LU, AYH
    JACOB, TA
    [J]. DRUG METABOLISM REVIEWS, 1987, 18 (2-3) : 289 - 302
  • [10] CHIU SHL, 1989, IVERMECTIN ABAMECTIN